Ernesto Vigna
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 50
- Multiple Myeloma Research and Treatments 26
- Acute Myeloid Leukemia Research 14
- Genetics 36
- Chronic Lymphocytic Leukemia Research 24
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Co-authors
- Massimo Gentile (71 shared papers)Fortunato Morabito (67 shared papers)Anna Grazia Recchia (12 shared papers)Francesco Mendicino (39 shared papers)Eugenio Lucia (43 shared papers)Enrica Antonia Martino (34 shared papers)Lucio Morabito (12 shared papers)Antonino Neri (33 shared papers)
- Journals
- European Journal Of Haematology (16 papers)Expert Opinion on Investigational Drugs (10 papers)Expert Opinion on Pharmacotherapy (8 papers)Blood (8 papers)Expert Opinion on Biological Therapy (4 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Ernesto Vigna
77 papers receiving 635 citations
Peers
Comparison fields: 5 of 71
- Hematology 316
- Genetics 178
- Oncology 193
- Pathology and Forensic Medicine 100
- Immunology 107
Countries citing papers authored by Ernesto Vigna
This map shows the geographic impact of Ernesto Vigna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto Vigna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto Vigna more than expected).
Fields of papers citing papers by Ernesto Vigna
This network shows the impact of papers produced by Ernesto Vigna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto Vigna. The network helps show where Ernesto Vigna may publish in the future.
Co-authors
The 25 scholars most cited alongside Ernesto Vigna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 45 | |
| 2 | 2017 | 42 | |
| 3 | 2015 | 41 | |
| 4 | 2008 | 29 | |
| 5 | 2016 | 25 | |
| 6 | 2011 | 24 | |
| 7 | 2021 | 23 | |
| 8 | 2015 | 22 | |
| 9 | 2013 | 17 | |
| 10 | 2014 | 17 | |
| 11 | 2010 | 16 | |
| 12 | 2009 | 15 | |
| 13 | 2016 | 15 | |
| 14 | 2017 | 14 | |
| 15 | 2003 | 14 | |
| 16 | 2011 | 14 | |
| 17 | 2018 | 13 | |
| 18 | 2010 | 13 | |
| 19 | 2021 | 13 | |
| 20 | 2013 | 13 |
About Ernesto Vigna
Ernesto Vigna is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 85 papers that have together received 649 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Chronic Lymphocytic Leukemia Research (24 papers), Protein Degradation and Inhibitors (18 papers), Lymphoma Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (14 papers), Peptidase Inhibition and Analysis (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Hematology (316 citations), Genetics (178 citations), Oncology (193 citations), Pathology and Forensic Medicine (100 citations) and Immunology (107 citations). Ernesto Vigna has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Massimo Gentile, Fortunato Morabito, Anna Grazia Recchia, Francesco Mendicino, Eugenio Lucia, Enrica Antonia Martino, Lucio Morabito, Antonino Neri, Anna Grazia Recchia and Massimo Martino. Their work appears in journals such as European Journal Of Haematology, Expert Opinion on Investigational Drugs, Expert Opinion on Pharmacotherapy, Blood and Expert Opinion on Biological Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.